$ktn.v
Kootenay Silver has moved from C$1.52 Friday close to C$1.81 today — a 19% single-day move with no press release. That is not noise. That is a signal. At 5x average volume with the broader market flat, this has the fingerprints of either a takeout approach or an imminent major catalyst like the La Cigarra PEA. Someone is accumulating aggressively.
The 52-week high is C$2.83 — so today's price is still 36% below the recent high, which tells you the stock has already demonstrated it can trade much higher and that a takeout at a meaningful premium to today still has room. #gold #silver #JuniorMining $CDE $AG $PAAS
My Best Estimate
Acceptable Takeout Range Scenario
Minimum friendly bid
C$3.00–3.50
Above 52-week high, management would likely reject below this
Fair value bid
C$4.50–6.00
2–3% of spot on resource base, comparable to peer transactions
Full value / competitive bid
C$7.00–10.00
If Columba hits 100M oz and PEA confirms strong economics
Dream scenario
C$12.00+
@MansfieldIntel@HormuzLetter And those delusional goat fkrs would have nukes... They are launching missiles at their neighbors now. It would be north Korea in the strait with nukes. It's now or never.
According recent data, gold and Gold related investments comprise about 1/2 of 1% of savings and investment assets, in the US. The 50 year median market share is reportadly 2%. Reversion to mean suggests a 4 fold increase in demand for this asset class
$NTLA It's mostly profit-taking after a recent run-up, plus the usual biotech volatility—nothing fresh like a clinical update or earnings drop today. The last big hit came late 2025 when a patient in their Phase 3 CRISPR trial for ATTR heart disease had severe liver issues and later died, triggering a clinical hold and a 40%+ crash.
FDA lifted those holds earlier this year (January and March 2026), and they've shared positive longer-term data on their HAE program, so the pipeline's back on track.
Analyst consensus is still Buy to Outperform, with average price targets around $20–$25—roughly 30–60% upside from here, though estimates range widely from $5 to over $100.
Intellia's a pure-play CRISPR gene-editing biotech, using one-time treatments to fix genetic diseases like hereditary angioedema and ATTR amyloidosis.
🔥The Silver Market Has Entered a Structural Tightness (SQUEEZE) Regime⚠️
💥Structural deficit regime: Silver has entered a multi-year shortage (6 straight deficits), with inventories steadily declining and no return to equilibrium in sight.
💥Supply cannot catch up: Modest mine growth and recycling are constrained by byproduct dynamics and bottlenecks, limiting the system’s ability to respond.
💥Demand is shifting, not falling: Industrial softness is being replaced by strong investment demand (coins, bars, ETFs), tightening the physical market further.
💥The ONLY resolution is price:
Click Below to Continue Reading on SilverTrade:
https://t.co/OOJrIbCIze
A whole convoy of empty oil tankers on the way to the US to fill up.
It could have been Canada but we have land acknowledgments to do and carbon tax instead.
@goldseek Wouldn't it been easier to just take delivery? It would have been a days operation. Unless of course the gold was never there, then this is the face saving move between central bankers. #gold#silver#Miningnews
@garrett4999@DonDurrett FVL is a huge position for Eric Sprott, the orignal GOAT. Just last week he was talking it up. Easy 10-20x from here as the gold in the ground gets repriced